Edoxaban Drug Profile

What is Edoxaban?

Edoxaban is a direct oral anticoagulant (DOAC) that belongs to the class of medications known as factor Xa inhibitors. It is used to prevent blood clots and reduce the risk of stroke in patients with certain heart rhythm disorders. This prescription medication works by directly blocking a key protein in the blood clotting process.

Uses

Edoxaban is approved for several important medical conditions:

• Atrial fibrillation: Reduces stroke risk in patients with nonvalvular atrial fibrillation, an irregular heart rhythm that increases clot formation risk
• Deep vein thrombosis (DVT): Treats blood clots that form in deep veins, typically in the legs
• Pulmonary embolism (PE): Treats potentially life-threatening blood clots that travel to the lungs
• Prevention of recurrent blood clots: Helps prevent DVT and PE from recurring after initial treatment
• Post-surgical clot prevention: May be used in certain patients to prevent clots after major orthopedic surgeries

How it works

Edoxaban works by directly inhibiting factor Xa, a crucial enzyme in the blood clotting cascade. By blocking this protein, edoxaban prevents the formation of thrombin, which is essential for converting fibrinogen into fibrin – the protein that forms blood clots. This selective inhibition reduces the blood’s ability to form dangerous clots while maintaining some clotting function for normal healing.

Side effects

Common side effects include:

Submit Your Paper

• Bleeding or bruising more easily than usual
• Nosebleeds
• Bleeding gums
• Heavy menstrual periods
• Fatigue
• Dizziness
• Headache
• Nausea

Serious side effects requiring immediate medical attention:

• Severe or uncontrolled bleeding
• Blood in urine or stool
• Coughing up blood
• Severe headache or confusion (potential signs of brain bleeding)
• Signs of internal bleeding such as severe abdominal pain

Warnings and precautions

• Bleeding risk: Patients with active bleeding, recent surgery, or high bleeding risk should not use edoxaban without careful medical supervision
• Kidney function: Dose adjustments are necessary for patients with moderate to severe kidney impairment, and the drug should be avoided in severe kidney disease
• Pregnancy and breastfeeding: Edoxaban may cause harm to developing babies and should generally be avoided during pregnancy; safety during breastfeeding is not established
• Artificial heart valves: Not recommended for patients with mechanical heart valves as effectiveness and safety have not been established
• Discontinuation: Stopping edoxaban suddenly can increase stroke and clot risk; transitions to other anticoagulants should be carefully managed by healthcare providers

Interactions

Edoxaban can interact with several medications and supplements:

• Rifampin: This antibiotic significantly reduces edoxaban effectiveness by increasing its breakdown in the body
• Antiplatelet drugs (aspirin, clopidogrel): Increase bleeding risk when combined with edoxaban
• Other anticoagulants (warfarin, heparin): Dramatically increase bleeding risk and should not be used together except during transition periods
• NSAIDs (ibuprofen, naproxen): May increase bleeding risk, especially gastrointestinal bleeding
• St. John’s wort: This herbal supplement may reduce edoxaban’s effectiveness
• Quinidine: This heart medication can increase edoxaban levels in the blood
• Dronedarone and verapamil: These heart medications may increase edoxaban concentrations
• Certain antifungal medications: Some azole antifungals may affect edoxaban metabolism

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary based on the condition being treated and individual patient factors. For atrial fibrillation, the standard dose is usually 60 mg once daily, with dose reduction to 30 mg for patients with certain risk factors including reduced kidney function, low body weight, or concurrent use of specific medications. For treating DVT and PE, the typical dose is 60 mg once daily after initial treatment with a parenteral anticoagulant. Dosing adjustments are often necessary based on kidney function, age, weight, and other medications. All dosing decisions should be made by a healthcare provider who can assess individual patient needs and risk factors.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).